In the conclusion of a two-part interview, Haleon CEO Brian McNamara and Lisa Paley, president of the O-T-C supplier’s North American business, discuss the self-care category’s standing in a post-COVID world. Among the issues addressed are the continued importance of Rx-to-O-T-C switches, steps that the company is taking to fuel innovation, and the need for both science and human understanding in shaping the business.
Video Forum: Brian McNamara and Lisa Paley, Haleon
In the conclusion of a two-part interview, Haleon CEO Brian McNamara and Lisa Paley, president of the O-T-C supplier’s North American business, discuss the self-care category’s standing in a post-COVID world.
Related
Kroger-Albertsons merger goes on trial in an Oregon federal court
The FTC faces off against lawyers from Albertsons and Kroger in a fight over competition in the grocery channel.
FDA approves Moderna’s updated COVID-19 vaccine
Moderna's updated COVID-19 vaccine targets the KP.2 variant of SARS-CoV-2 to help prevent COVID-19 in individuals 6 months of age and older.
Kroger sues FTC, claims merger challenge violates Constitution
The company argues that by proceeding in its administrative tribunal, in addition to the separate action in federal court, the FTC is violating Constitutional protections.
CRN to Federal Appeals Court: NY AG’s arguments don’t support denial of preliminary injunction in NY age restrictions case
CRN’s most recent brief argues that the NY AG does not meaningfully address CRN’s arguments about the Act’s constitutional infirmities.
Latest
WSJ: Trump to fire FDA chief
Makary’s departure would mark the latest shakeup among top federal health officials under the Trump administration.
CRN launches Sergeant Searchlight campaign for supplement transparency
Through a comic-style social media campaign, CRN is advocating for supplement transparency legislation designed to improve FDA visibility into products on the market.
Port imports to decline after May-June bump
Import cargo volumes at major U.S. ports are expected to stay below last year’s levels into early fall, despite temporary May and June gains.
GLP-1 hydration market to reach $6 billion by 2036
Hydration products designed for GLP-1 medication users are a fast-growing category across wellness and pharmacy channels, driven by demand for low-sugar, digestive-friendly options.